Nulojix

Active Ingredient(s): Belatacept
FDA Approved: * June 15, 2011
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Immunosuppressive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Nulojix Overview

Belatacept (trade name Nulojix) is a fusion protein composed of the Fc fragment of a human IgG1 immunoglobulin linked to the extracellular domain of CTLA-4,[1] which is a molecule crucial in the regulation of T cell costimulation, selectively blocking the process of T-cell activation. It is intended to provide extended graft and transplant[2] survival while limiting the toxicity generated by standard immune suppressing regimens, such as calcineurin inhibitors. ...

Read more Nulojix Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Belatacept

Recent Nulojix Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Belatacept
  • Injection: 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nulojix: (1 result)

Sorted by National Drug Code
  • 0003-0371 Nulojix 250 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by E.r. Squibb & Sons, L.L.C.

Other drugs which contain Belatacept or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA